TY - JOUR
T1 - Impact of Season, Environmental Temperature, and Humidity on Raynaud Phenomenon in an Australian Systemic Sclerosis Cohort
AU - Taylor, Laura
AU - Hansen, Dylan
AU - Morrisroe, Kathleen
AU - Fairley, Jessica
AU - Calderone, Alicia
AU - Oon, Shereen
AU - Ross, Laura
AU - Stevens, Wendy
AU - Ferdowsi, Nava
AU - Quinlivan, Alannah
AU - Sahhar, Joanne
AU - Ngian, Gene-Siew
AU - Apostolopoulos, Diane
AU - Host, Lauren V.
AU - Walker, Jennifer
AU - Tabesh, Maryam
AU - Proudman, Susanna
AU - Nikpour, Mandana
N1 - Publisher Copyright:
© 2024 American College of Rheumatology.
PY - 2025/1
Y1 - 2025/1
N2 - Objective: The aim of this study was to determine the impact of season, temperature and humidity on the severity of Raynaud phenomenon (RP) in systemic sclerosis. Methods: Data from the Australian Scleroderma Cohort Study were used to assess associations of patient-reported worsened RP in the month preceding each study visit. Mean monthly weather data were obtained from the closest weather station to the patient's address. We evaluated the relationship between worsened RP and health-related quality of life (HRQoL) measured using the Short Form 36 instrument. Results: Among 1,972 patients with systemic sclerosis, RP was a near-universal finding, and worsened RP in the preceding month was reported in 26.7% of 9,175 visits. “Worsened RP” showed significant environmental variability. On multivariable analysis, worsened RP was associated with low mean maximum temperatures (odds ratio [OR] 0.91, 95% confidence interval [95% CI] 0.90–0.92, P < 0.001), high relative humidity (OR 1.05, 95% CI 1.04–1.05, P < 0.001) and lower mean daily evaporation (OR 0.77, 95% CI 0.73–0.81, P < 0.001). Worsened RP was strongly associated with telangiectasia, calcinosis, and digital ulceration, as well as demonstrating an association with anticentromere antibody and gastroesophageal reflux disease and a negative correlation with diffuse disease. Worsened RP was also strongly associated with worse HRQoL. Conclusion: Lower environmental temperature and higher relative humidity had significant associations with worsened RP in this systemic sclerosis cohort, suggesting an important role for dry warmth in managing this condition.
AB - Objective: The aim of this study was to determine the impact of season, temperature and humidity on the severity of Raynaud phenomenon (RP) in systemic sclerosis. Methods: Data from the Australian Scleroderma Cohort Study were used to assess associations of patient-reported worsened RP in the month preceding each study visit. Mean monthly weather data were obtained from the closest weather station to the patient's address. We evaluated the relationship between worsened RP and health-related quality of life (HRQoL) measured using the Short Form 36 instrument. Results: Among 1,972 patients with systemic sclerosis, RP was a near-universal finding, and worsened RP in the preceding month was reported in 26.7% of 9,175 visits. “Worsened RP” showed significant environmental variability. On multivariable analysis, worsened RP was associated with low mean maximum temperatures (odds ratio [OR] 0.91, 95% confidence interval [95% CI] 0.90–0.92, P < 0.001), high relative humidity (OR 1.05, 95% CI 1.04–1.05, P < 0.001) and lower mean daily evaporation (OR 0.77, 95% CI 0.73–0.81, P < 0.001). Worsened RP was strongly associated with telangiectasia, calcinosis, and digital ulceration, as well as demonstrating an association with anticentromere antibody and gastroesophageal reflux disease and a negative correlation with diffuse disease. Worsened RP was also strongly associated with worse HRQoL. Conclusion: Lower environmental temperature and higher relative humidity had significant associations with worsened RP in this systemic sclerosis cohort, suggesting an important role for dry warmth in managing this condition.
UR - https://www.scopus.com/pages/publications/85208651288
U2 - 10.1002/acr.25452
DO - 10.1002/acr.25452
M3 - Article
C2 - 39420564
AN - SCOPUS:85208651288
SN - 2151-4658
VL - 77
SP - 61
EP - 68
JO - Arthritis Care & Research
JF - Arthritis Care & Research
IS - 1
ER -